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Preexposure to a low dose of interleukin-1 (IL-1; 3 to 30 |xg/kg) 24 h before a lethal gram-negative bacterial 
infection prolonged survival in normal and granulocytopenic mice. To examine whether this protective effect 
is mediated by glucocorticosteroids, we first measured corticosterone concentrations in mice after administra­
tion of 80 and 800 ng of IL-1. IL-1 induced a dose-dependent increase in corticosterone levels in plasma. Next, 
the corticosterone peak induced by a protective dose of IL-1 (800 ng) was simulated by administration of 
synthetic human adrenocorticotropic hormone 1-24 (ACTH) in normal and neutropenic mice. Although 
corticosterone levels induced by pretreatment with IL-1 or ACTH were virtually identical, the ACTH-induced 
corticosterone peak was not associated with protection against Klebsiella pneum oniae  infection in normal mice 
and Pseudomonas aeruginosa infection in neutropenic mice. This indicates that the protective effect of IL-1 
pretreatment against gram-negative bacterial infection is not mediated by elevated levels of glucocorticoster­
oids. In addition, we found that plasma corticosterone concentrations during K. pneumoniae  infection were 
significantly lower after pretreatment with IL-1 than after pretreatment with ACTH or vehicle, probably 
reflecting the better physical condition of IL-l-treated mice.
Interleukin-1 (IL-1), a 17-kDa protein  p roduced  by m any 
different types  of  cells, has a var ie ty  of  immunologic and 
inflammatory  effects (9). W hen  injected into experim enta l  
animals,  IL-1 is able to enhance  nonspecific res is tance  to 
several  gram -posit ive  and gram -negative  bacteria ,  fungi, and 
p lasm odia  (30). F o r  exam ple ,  we have show n that t rea tm ent  
with a single low dose (80 to 800 ng) of recom binan t  hum an 
I L - l ß  ( rh IL - lß )  24 h before a lethal challenge with gram- 
negative bac ter ia  prolongs survival in normal and g ranu lo ­
cy topen ic  mice (24, 25). The  m echan ism  of the pro tective  
effect of  IL-1 has not been e lucidated .  A  direct antimicrobial 
effect o f  IL-1 has been exc luded  in v itro  (25). W h e th e r  IL-1 
induces enh an ced  c learance  of  m icroorgan ism s in v ivo is 
con trovers ia l  (13, 14, 24, 25, 27). The p resence  of  a p ro te c ­
tive effect of IL-1 to infectious challenges in g ranu locy ­
topenic  mice p rov ides  ev idence  for the lack of  a m ajor role of 
neutrophils  (13, 25, 27, 30). The  lack o f  effect o f  p re t re a t ­
m ent with  cyc lo -oxygenase  inhibitors or recom binan t  cy to ­
kines on the ability of  mice to surv ive  infection also indicates 
that  the induction of  cyc lo -oxygenase  m etaboli tes  or c y to ­
kines like IL -6, IL -8 , o r  tum or  necrosis  factor alpha by IL-1 
likely does  not accoun t  for the IL - l - in d u ced  res is tance
(24-26, 28-30).
Injection of IL-1 into mice ac tivates  the pitu itary-adrenal 
axis; this is m anifested  by  increased  levels o f  ad ren o co r t i ­
co trop ic  ho rm one  (A CTH ) and co r t icos te rone  in p lasm a (5). 
T he  fact tha t  adm inis tra tion  of  g lucocort icos te ro ids  has been 
show n to increase  survival of septic  animals (17, 21) raises 
the question  o f  w h e th e r  the p ro tec t ive  effect of IL-1 might be 
due to IL - l - in d u c ed  enhanced  secre t ion  of these horm ones .  
To  address  this issue, w e  m easu red  the co r t icos te rone  
re sp onses  induced by different dosages of  r h I L - lß .  F u r th e r ­
m ore ,  w e  s im ulated  the IL - l - in d u ced  co r t icos te rone  peaks 
by adm inis tra t ion  of  syn the t ic  hum an A C T H (1_24| (ACTH)
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and assessed  the effect of adm inistra tion  of A C T H  on 
survival in infected normal and neu tropen ic  mice. To find 
out w h e th e r  p ro tection  w as  associa ted  with changes  in 
p lasm a co r t icos te rone  concen tra t ions ,  w e m easured  postin- 
fectious co r t icos te rone  concen tra t ions  in mice t rea ted  with 
IL-1 or  A C T H  as well.
(Part of  this report  w as  p resen ted  at the Third In te rn a ­
tional W o rk sh o p  on C ytok ines ,  10 to 14 N o v e m b e r  1991, 
S tresa ,  Italy [28a].)
MATERIALS AND METHODS
Mice. Fem ale  ou tb red  Swiss mice (weight, 30 to 40 g; 
T N O ,  Rijswijk, The N etherlands)  w ere  kept under  specific- 
pathogen-free  condit ions in an artificially lighted room  with a 
light-dark cycle o f  12 h (lights on at 7 a .m . ,  lights off at 7 
p .m .) .  F o r  exper im en ts  in which co r t icos te rone  levels w ere  
m easu red ,  the mice w ere  housed  individually for 4 to 5 days 
prior to initiation of  the s tudies .  S tandard  lab chow  (RM H- 
TM ; H o pe  F arm s ,  W oerden ,  The  N etherlands)  and acidified 
w a te r  w ere  available ad libitum. G ranu locy topen ic  mice 
received  irradiated food.
Materials. r h I L - l ß  w as  kindly provided  by P. G raber  
(Glaxo, G eneva ,  Switzerland) and P. Ghiara  (Sciavo, Siena, 
Italy). A ccord ing  to the specifications of  the suppliers ,  
endotoxin  con tam ination  w as  negligible (<1 .53  and < 1 .2  
ng/mg, respectively).  IL-1 w as  s to red  undiluted at - 7 0 ° C  
and w as  diluted immediately  before use in pyrogen-free 
isotonic phosphate-buffered  saline (pH  7.4). Inactivated  IL-1 
w as  p repared  by heating IL-1 at 95°C for 30 min. H u m an  
A C T H (1_24j (Synacthen ;  C IB A -G E IG Y , A rnhem , The  N e th ­
erlands) w as  diluted in pyrogen-free  saline. To all so lutions,  
including contro l  t rea tm en ts  (saline), normal m ouse  serum  
w as  added  to an end vo lum e of  2% (vol/vol). Gentam icin  w as  
pu rchased  from Schering, K en ilw orth ,  N .J .  C y c lo p h o sp h a ­
mide (A ST A  P harm a,  F rankfu r t ,  G erm any)  w as  dissolved in 
sterile pyrogen-free  distilled w ate r .  Bacterial  challenges
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[Klebsiella pneumoniae  A T C C  43816 and Pseudomonas 
aeruginosa A T C C  27853) w ere  p repared  by appropria te  
dilution of  overnight cu ltu res ,  and cu ltures  w ere  w ashed  
three  times in saline.
Experimental procedures. All exper im en ts  s ta r ted  at 9:30
a.m . (time zero).
(i) Corticosterone levels after treatment with IL-1 or ACTH. 
F o r  single t rea tm en ts ,  mice received 80 or 800 ng of  IL-1 
in traperitoneally  (i.p.), 50 jxg o f  A C T H  su bcu taneous ly  
(s.c.),  or vehicle s .c .  at time zero . In exper im en ts  in which 
two t rea tm en ts  with 50 |j.g of A C T H  s.c .  w ere  given, these 
injections w ere  adm inis tered  at time zero  and 1.5 h. In these 
exper im en ts ,  mice that w ere  treated  with IL-1 i.p. or vehicle 
s .c .  at time zero  received vehicle  s .c .  at 1.5 h. For  four 
t rea tm en ts  with 50 ^g  of  A C T H , the injections w ere  given at
0, 1.5, 6 , and 10 h. In these exper im en ts ,  mice t rea ted  with 
IL-1 or vehicle  at time zero  received vehicle at the o ther  time 
points. At var ious  time points after the first injection, mice 
w ere  decap ita ted  and blood w as  collected in E D T A -coa ted  
tubes. Plasma w as  s tored  at - 2 0 ° C  until it w as  assayed .  For  
co r t icos te rone  m easu rem en ts  in neu tropen ic  mice, n eu t ro ­
penia (< 0 .5  x 10g po lym orphonuc lea r  leukocy tes  per liter) 
w as  induced by two s .c .  injections of cyc lophospham ide  (150 
mg/kg on day  - 3  and 100 mg/kg on day  0, before the 
t rea tm en ts  described  above).
(ii) Effects of IL-1 and ACTH pretreatment on survival. For 
survival exper im en ts ,  som e mice w ere  rendered  neu tropen ic  
as described  above .  P re trea tm en ts  with IL-1, A C T H  (one, 
two, or  four adm inis tra t ions) ,  or  vehicle w ere  given as 
descr ibed  above .  The infectious challenge w as  adm inis tered  
24 h after the first injection. N ongranu locy topcn ic  mice 
received K. pneumoniae  in tram uscularly  (i.m.) (1 x 10f1 to 5 
x  106 C F U  per mouse),  w h e re a s  g ranu locy topen ic  mice 
received P. aeruginosa i.m. (0.5 x 10s to 1 x  10s C F U  per 
mouse).  Six hours  after the challenge, 120 mg of gentamicin 
per kg of  body  weight was given s .c .  in o rd e r  to pos tpone  the 
time of death and thus accen tua te  the differences be tw een  
t rea tm en t  groups.  M ortali ty  w as  recorded  for a period of at 
least 48 h after challenge.
(iii) Effects of IL-1 and ACTH pretreatment on corticoster­
one levels during infection. For  co r t icos te rone  m easu rem en ts  
during infection, nonneu tropen ic  mice w ere  p re trea ted  24 h 
before the challenge with e i ther  800 ng of IL-1 o r  two doses 
of  50 jxg of A C T H  or vehicle as descr ibed  above .  K. 
pneumoniae  (1 x 10'1 to 5 x 106 C F U  per  m ouse) was 
adm inis tered  i.m.; this w as  followed 6 h later by t rea tm ent  
with 120 mg of gentamicin  per kg s .c .  P lasma for co r t ico ­
s te rone  m easu rem en ts  w as  collected at var ious  time points 
after the infectious challenge, and the m orta li ty  and physical 
condition  of  the mice w ere  observed .
Assays. C ort icos te rone  concen tra t ions  in p lasm a were  
de term ined  by a specific and sensitive rad io im m unoassay  
described  by Sw eep  et al. (20).
Statistical analysis. Survival cu rves  w ere  ana lyzed  by the 
log rank  test (16). C om par isons  of m edians  of co r t icos te rone  
levels be tw een  t rea tm en t  g roups  w ere  made by the Kruskal 
Wallis test  at each time point (11). P va lues  o f  <0.05 w ere  
cons idered  statistically significant.
RESULTS
Corticosterone levels after IL-1 treatment. The co r t ico s te r ­
one response  (median values) in nonneu tropen ic  mice to i.p. 
injection of  80 and 800 ng of IL-1 is show n in Fig. 1A. Plasma 
co r t icos te rone  levels peaked  (3.17 fimol/liter) 2 h after 
injection o f  80 ng of  IL-1, and the concen tra t ion  re tu rned  to
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FIG. 1. (A) Median plasma corticosterone values in normal mice 
after injection of 80 or 800 ng of rh IL - lß  i.p. at time zero (six mice 
per datum point). Differences between the group treated with 80 ng 
of IL-1 and the control treatment group were significant at 1, 2, and 
4 h after injection (P  = 0.007, 0.001, and 0.01, respectively). 
Differences between the group treated with 800 ng of IL-1 and the 
control treatment group were significant at 0.5, 1, 2, and 4 h after 
injection (P  = 0.05, 0.002, 0.03, and 0.0005, respectively). The 
difference between groups treated with 80 ng of IL-1 and 800 ng of 
IL-1 was significant at 4 h after injection (P  = 0.0001). (B) Median 
plasma corticosterone levels after injection of 800 ng of rh IL - lß  i.p. 
at time zero or one, two, or four s.c. injections of 50 ^g of 
A C T H ij^ ji  or control treatment at time zero and 1.5, 6 , and 1 0  h (six 
mice per datum point). Differences between groups treated with 800 
ng of IL-1 and one injection of ACTH were significant at 1, 4, and 8 
h after injection (P  = 0.002, 0.004, and 0.006, respectively). The 
difference between groups treated with 800 ng of IL-1 and two 
injections of ACTH was significant at 8 h [P  = 0.02). The difference 
between groups treated with 800 ng of IL-1 and four injections of 
ACTH was significant at 12 h (P  = 0.002).
control levels at 8 h. The  differences with the veh ic le- trea ted  
group reached  statistical significance at 1, 2, and 4 h after 
injection. Plasma co r t icos te rone  levels after injection of  800 
ng of  IL-1 peaked  4 h after injection (3.48 (jimol/liter) and 
re turned  to control  levels at 16 h. Significant differences with 
veh ic le- trea ted  mice w ere  p resen t  at 0.5, 1, 2, and 4 h after 
IL-1 injection. A significant difference be tw een  the groups 
treated  with 80 and 800 ng of  IL-1 w as  p resen t  4 h after 
injection.
In neu tropen ic  mice, co r t icos te rone  levels after adm inis­
tration of 800 ng of  IL-1 peaked  at 2 h after injection (2.89 
jxmol/liter) and re tu rned  to the va lues  for control mice at 12
h. Significant differences with veh ic le- trea ted  neu tropen ic  
mice w ere  p resen t  at 1 , 1.5, 2 , and 4 h after  injection. The
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co r t ico s te rone  levels induced by  IL-1 o r  four injections of  
A C T H  in neu tropen ic  mice did not differ significantly at any 
time point (data not shown).
T he  c ircad ian  rhy thm  of co r t icos te rone  levels obse rved  in 
p lasm a of  mice t rea ted  with vehicle  w as  similar to that  in 
p lasm a of  un trea ted  mice repor ted  by  o thers  (10). The  low 
basal co r t ico s te ro ne  levels in veh ic le - trea ted  mice indicate 
that b lood sampling took  place under  relatively stress-free  
c i rcum stances .
Simulation of IL-l-induced increased corticosterone levels 
by administration of ACTH. C ort icos te rone  concen tra t ions  
(median values)  in p lasm a after adm inis tra t ion  of  800 ng of  
IL-1 and after one ,  two, or four consecu t ive  injections o f  50 
[xg of  A C T H  in normal mice are dep ic ted  in Fig. IB .  Plasma 
co r t ico s te rone  levels after one injection of  A C T H  peaked  at
1 h after  injection (3.59 jxmol/liter) and reached  levels not 
significantly different from those in contro l  mice at 8 h.
T he  co r t ico s te ron e  levels after  tw o injections of A C T H  
w ere  not significantly different from the levels induced by 
IL-1, with the excep tion  of  the va lue  ob ta ined  8 h after 
injection, at w hich  time point co r t ico s te rone  levels w ere  
significantly higher after IL-1 adm inis tra t ion .  F o u r  injections 
of  A C T H  p roduced  a co r t icos te rone  peak  w hich  lasted 
longer than the IL - l - in d u c ed  peak ,  the A C T H -in duced  level 
being significantly g rea te r  than the IL - l - in d u ced  level 12 h 
after  injection. W hen  the sam e regimen of 800 ng of  IL-1 or 
four A C T H  injections w as  adm in is tered  to neu tropen ic  
mice, p lasm a co r t icos te rone  concen tra t ion  cu rv es  did not 
differ significantly at any time point (data not show n).  After
i.p. injection o f  0.1 ml o f  IL-1 vehicle  with 800 ng of 
hea t- inac t iva ted  IL-1 and s .c .  injection of  0.2 ml of saline, 
similar co r t ico s te ron e  levels w ere  ob se rv ed  (data not 
show n).  This  indicates that differences in the route  of 
adm in is tra t ion ,  injection vo lum e,  and vehic les  for t rea tm en t  
with IL-1 v e rsu s  A C T H  or contro l  therapy  do not induce 
different co r t icos te rone  responses .  Since additional s .c .  v e ­
hicle injections also did not significantly alter  co r t icos te rone  
levels, only the levels of  the i.p. contro l  g roup  are p resen ted  
in Fig. IB .
In infection exper im en ts ,  two and four doses  of  A C T H  
w ere  used to induce co r t icos te rone  responses .
Effect of IL-1 and ACTH on survival. P re trea tm en t  of 
normal mice with 800 ng of IL-1 24 h before  an i.m. infection 
with K. pneumoniae  significantly en h an ced  survival (Fig. 
2A). To  investigate w h e th e r  this p ro tec t ive  effect w as  m ed i­
ated by the enh an ced  p lasm a co r t icos te rone  level induced by 
IL-1, the effect of  two A C T H  doses  on survival w as  a s ­
sessed .  Despite  the similar co r t icos te rone  pa t te rns  after IL-1 
and A C T H  trea tm en ts ,  the p ro tec t ive  effect o f  IL-1 could 
not be rep rodu ced  by  A C T H  adm inis tra t ion  (Fig. 2A). W hen 
these  t rea tm en ts  w ere  given to g ranu locy topen ic  mice before 
an i.m. P. aeruginosa infection, IL-1 enhanced  survival 
significantly, while A C T H  had no effect at all co m p ared  with 
the effect of  control the rapy  (Fig. 2B).
W hen  four doses  of  A C T H  w ere  adm in is te red ,  which 
p ro d u ced  larger co r t icos te rone  peaks  than those  p roduced  
with IL-1, no p ro tec t ion  w as  ob se rv ed  in normal mice 
infected with K. pneumoniae  (Fig. 2C) or  g ranu locy topen ic  
mice infected with P. aeruginosa (Fig. 2D).
Effect of IL-1 and ACTH pretreatment on corticosterone 
levels during infection. Mice w ere  infected with K. pneum o­
niae after  p re t rea tm en t  with 800 ng of  IL-1, two doses  of 50 
jxg of  A C T H ,  or vehicle  injection. As ex p ec ted ,  app rox i­
m ately  20% of contro l  and A C T H -trea ted  mice died during 
the expe r im en t ,  while all of  the IL - l - t re a te d  mice surv ived  
for 48 h. P lasm a co r t icos te rone  levels w ere  increased  for 6 to
time (h> time (h)
FIG. 2. (A) Survival of normal mice infected i.m. at time zero 
with K. pneumoniae after pretreatment at - 2 4  h with 800 ng of 
rh IL - lß  i.p., two doses of A C T H m 24) s . c . ,  or vehicle s.c. at - 2 4  and 
-2 2 .5  h (36 mice per group). Differences between IL-l-treated  and 
control mice were significant (x2 =  8.56; P  < 0.01). Differences 
between ACTH-treated and control mice were not significant. (B) 
The same experiment as described for panel A in granulocytopenic 
mice infected i.m. with P. aeruginosa (24 mice per group). Differ­
ences between IL-l-treated  and control mice were significant (x2 = 
9.94; P  < 0.005), whereas differences between ACTH-treated and 
control mice were not significant. (C) Survival of normal mice 
infected i.m. with K. pneumoniae at time zero after pretreatment at 
- 2 4  h with 800 ng of rh IL - lß  i.p. or four doses of A C T H [1_24) or 
control treatment s.c. at - 2 4 ,  -2 2 .5 ,  - 1 8 ,  and - 1 4  h (48 mice per 
group). Differences between IL-l-treated  and control mice were 
significant (x2 = 4.30; P  < 0.05). Differences between ACTH-treated 
and control mice were not significant. (D) The same experiment as 
described for panel C in granulocytopenic mice infected i.m. with P. 
aeruginosa (24 mice per group). Differences between IL-l-treated 
and control mice were significant (x2 = 10.34; P  < 0.005), whereas 
differences between ACTH-treated and vehicle-treated mice were 
not significant.
12 h after infection in all t rea tm en t  g roups  (Fig. 3). The  
co r t icos te rone  concen tra t ion s  in veh ic le - trea ted  and A C T H - 
trea ted  mice did not differ significantly at any  time point. In 
IL - l - t re a te d  mice, how ever ,  co r t ico s te rone  levels w ere  
lower than those  in the contro l  mice (significantly different at 
36 and 48 h) and the A C T H -trea ted  group  (significantly 
different at 12 and 36 h) (Fig. 3). Signs of d iscom fort  of  the 
infected animals (piloerection, dec reased  physical activity) 
w ere  less p ro n o u n ced  in the IL - l - t re a te d  group.
DISCUSSION
In the p resen t  s tudy  w e  exam ined  the role of  g lucocort i ­
cos te ro ids  in IL - l - in d u ced  pro tec t ion  to a lethal bacterial  
challenge in mice. P reexposu re  to 800 ng of IL-1 24 h before 
a gram -negative  bacteria l  challenge enhances  survival in 
normal and neu tropen ic  mice (24, 25). A dm in is tra t ion  of  a 
low dose (800 ng) o f  r h I L - l ß  to bo th  normal o r  neu tropen ic  
mice resulted  in an e leva ted  p lasm a co r t icos te rone  level for
8 to 12 h; this is similar to w ha t  o the r  investigators  have 
found in non neu trop en ic  mice (5). Several  investigators  have 
s tudied  the adm inis tra t ion  o f  g lucocor t icos te ro ids  shortly
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F1G. 3. Median corticosterone levels after i.m. infection at time 
zero of normal mice with K. pneumoniae 24 h after pretreatment 
with 800 ng of rh IL - lß ,  two doses of 50 jxg of ACTH[1_24|, or control 
treatment (six mice per datum point). Corticosterone levels after 
IL-1 pretreatment were significantly lower than those in control 
treated mice at 36 and 48 h [P  = 0.03 and P  = 0.02, respectively) and 
than those in ACTH-treated mice at 12 and 36 h (P  = 0.04 and P  =
0.009, respectively). Differences between ACTH-treated and con­
trol groups were not significant.
before or  after a challenge with endo tox in ,  m icroorgan ism s, 
or  o th e r  noxious su b s tan ces  and found that they have a 
p ro tec t ive  effect on survival (1, 8 , 17). A lthough plasma 
co r t icos te rone  concen tra t ion s  in our  s tudy  peaked  20 h 
before the infectious challenge and re tu rned  to normal at the 
time of infection, a p ro tec t ive  effect by the transiently  
increased  level of co r t icos te rone  canno t  be exc luded  a 
priori, since several  effects of g lucocort icos te ro ids  are long- 
lasting or  are delayed for m any  hours  (2, 15, 19, 31). Also, 
our  finding of  a difference in co r t icos te rone  levels induced by 
a p ro tec tive  (800 ng) ve rsus  a nonpro tec t ive  (80 ng) dose of  
IL-1 might be in acco rdance  with a role of  g lucoco r t icos te r ­
oids in the p ro tec t ive  effect o f  IL-1. H o w e v e r ,  w hen  we 
m im icked the p lasm a co r t icos te rone  concen tra t ion  curve 
induced by 800 ng of  IL-1 by adm inis tra t ion  of  syn the tic  
hum an A C T H  to both  normal and neu tropen ic  mice, no 
pro tec t ion  against lethal bacterial  infection w as  found. This 
indicates that p ro tec t ion  by IL-1 is not m edia ted  by the 
e leva ted  levels of  g lucocort icos te ro ids .  •
During infection, levels of  g lucocort ico ids  in p lasm a in­
crease .  The  early  p resence  of adequa te  con cen tra t io ns  of 
g lucocort icos te ro ids  is p robab ly  necessa ry  for effective c o n ­
trol of overshoo ting  of  the normal defense  reac t ions  that 
occu rs  during infection and injury (3, 15). G lu co co r t ico s te r ­
oids sup p ress  the p roduc t ion  and the effects of  m any  of  the 
m edia to rs  that play a role in tissue injury in severe  infections 
(7). P roduction  of p r im ary  m ed ia to rs ,  like the cy tok ines  
IL-1, tum or  necros is  factor ,  IL -6 , and gam m a in terferon, 
and se co n d a ry  m edia to rs  is inhibited by g lucocort icos te ro ids  
(6 , 12, 15, 18, 23). In addit ion , g lucocor t icos te ro ids  play a 
role in the induction of  the secre t ion  of  acu te -phase  pro te ins ,  
m any  of  which possess  anti- inflam m atory  and detoxifying 
effects (22). A physiological role of  these  ho rm ones  during 
infection is further  su pp o r ted  by the increased  sensit iv ity  of 
ad rena lec tom ized  roden ts  to the toxic effects of  endo tox in ,  
inflam m atory  cy tok ines ,  and o the r  inflammatory m edia to rs ,  
a sensit iv ity  that can be reversed  by  adm inis tra t ion  of 
g lucocor t icos te ro ids  (3, 4). In var ious  s tud ies  of gram-
negative sepsis  and endo tox in  shock  in animals,  increased  
survival after high-dose g lucocort icostero id  p re t rea tm en t  
has been d ocu m en ted  (17, 21). T here fo re ,  w e also exam ined  
the im pact of  IL-1 p re t rea tm en t  on the g lucocort ico id  re ­
sponse  after  an infectious challenge. In terest ingly ,  w e found 
lower co r t icos te rone  levels in IL - l -p re t r e a te d  mice during 
infection. Since the IL - l - t rea te d  mice all su rv ived  the cha l­
lenge, these relatively  low co r t icos te rone  levels m ay  reflect 
the be t te r  physical condition of these  mice; the higher 
s tero id  levels in the vehicle- and A C T H -trea ted  mice might 
be a co n seq u en ce  of  the lethal illness.
In conc lus ion ,  the data  p resen ted  here suggest that the 
increase  in res is tance  to infection induced by  IL-1 is not due 
to the effect o f  this cy tok ine  on g lucocor t icos te ro id  p ro d u c ­
tion. The  im proved  ou tcom e  of infection in animals trea ted  
with IL-1 is assoc ia ted  with lower p lasm a co r t icos te rone  
levels during the cou rse  o f  infection.
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